Media Overview | Boehringer Ingelheim MEA

Media Overview

Boehringer Ingelheim’s Hub for providing you with the latest Press Releases and further Press Material for Download.

Press Releases

[Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim](/content/mea/human-health/lung-diseases/emirates-drug-establishment-approves-new-lung-disease-treatment-boehringer-ingelheim "Emirates Drug Establishment Approves a new Lung Disease Treatment from Boehringer Ingelheim"/index.html)

June 26, 2026

[Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event](/content/mea/human-health/metabolic-diseases/footballs-yellow-card-becomes-call-action-cardiovascular-renal-and-metabolic-health-boehringer "Football’s Yellow Card Becomes a Call for Action on Cardiovascular, Renal, and Metabolic Health at Boehringer Ingelheim’s CRM United Event"/index.html)

November 24, 2025

[FIBRONEER™ global phase III trials](/content/mea/human-health/lung-diseases/pulmonary-fibrosis/fibroneer-global-phase-iii-trials "FIBRONEER™ global phase III trials"/index.html)

June 04, 2025

Media Contacts

Feda Kassem

Manager, Corporate Communications, IMETA, Corporate Affairs

Atalia Faria

Specialist, Communications IMETA, Corporate Affairs

Current Events

Please check back later!

There are no upcoming events in the near future.

Past Events

[Annual Results Press Conference 2022](/content/mea/annual-results-press-conference-2022 "Annual Results Press Conference 2022"/index.html)

Event

Annual Results Press Conference 2022

Press Material

Access our media pool and Animal Health press kit.
Read more

References